ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Gene Vector Labs Seek Vector Producers

February 23, 1996

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

New England Medical Center Discloses Case Of Two Overdoses

April 28, 1995

Spending Bill Expected At White House Any Day Now; NIH Awaits 15% Increase.

October 27, 2000

In Brief: Benacerraf, Snell, Dausset Win Nobel Prize; AACE Seeks Increase In Clinical Education Funds

October 17, 1980

Funding Opportunities

December 6, 2002